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Abstract
Genetic susceptibility to common conditions, such as essential hypertension and cardiac 
hypertrophy, is probably determined by various combinations of small quantitative changes in the 
expression of many genes. NPR1, coding for natriuretic peptide receptor A (NPRA), is a potential 
candidate, because NPRA mediates natriuretic, diuretic, and vasorelaxing actions of the nariuretic 
peptides, and because genetically determined quantitative changes in the expression of this gene 
affect blood pressure and heart weight in a dose-dependent manner in mice. To determine whether 
there are common quantitative variants in human NPR1, we have sequenced the entire human 
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NPR1 gene and identified 10 polymorphic sites in its non-coding sequence by using DNA from 34 
unrelated human individuals. Five of the sites are single nucleotide polymorphisms; the remaining 
five are length polymorphisms, including a highly variable complex dinucleotide repeat in intron 
19. There are three common haplotypes 5’ to this dinucleotide repeat and three 3’ to it, but the 5’ 
haplotypes and 3’ haplotypes appear to be randomly associated. Transient expression analysis in 
cultured cells of reporter plasmids with the proximal promoter sequences of NPR1 and its 3’ 
untranslated regions showed that these polymorphisms have functional effects. We conclude that 
common NPR1 alleles can alter expression of the gene as much as two-fold and could therefore 
significantly affect genetic risks for essential hypertension and cardiac hypertrophy in humans.
Introduction
Common variations in genes are increasingly recognized as important contributors to the 
genetic susceptibility to complex diseases such as essential hypertension and cardiac 
hypertrophy. Although the genetic contribution to hypertension is estimated to be 30%–60% 
(Ward 1990; Turner and Boerwinkle 2000; Verhaaren et al. 1991), very few genetic 
mutations have been linked to it in humans. Mutations in several genes are known to cause 
Mendelian forms of hypertension (Lifton et al. 2001), but their occurrence is too infrequent 
to contribute appreciably to hypertension in the population as a whole. In contrast, small 
differences that occur with high allelic frequencies and have additive effects are more likely 
to have impacts in a large population. These include quantitative alterations in gene 
expression governed by polymorphisms in non-coding sequences.
Even with the completion of the human genome sequence and the rapid accumulation of 
genome-wide single nucleotide polymorphisms (SNPs), the study of multi-genic diseases 
remains a great challenge (Peltonen and McKusick 2001; Cargill et al. 1999; Halushka et al. 
1999). Small effects of individual polymorphisms are not readily recognized in association 
studies and, even when found, must be tested in animal models to determine that they are 
causative. Conversely, there are several gene systems in which a causative link between 
quantitative changes in gene expression and a cardiovascular phenotype has been 
demonstrated in animals but not in humans. Common polymorphisms in these genes in 
humans, if they have quantitative effects on expression could consequently have important 
implications in the population. Quantitative differences in expression of the NPR1 gene, 
which codes for the natriuretic peptide receptor A (NPRA), has cardiovascular consequences 
in mice and is therefore such a candidate gene for hypertension and cardiac hypertrophy in 
humans.
NPRA is a membrane-bound guanylate cyclase that serves as the receptor for both atrial and 
brain natriuretic peptides (ANP and BNP, respectively) and is important in the maintenance 
of cardiovascular homeostasis (Chinkers et al. 1989). In response to increases in blood 
volume or blood pressure, ANP and BNP are released from the heart and act through NPRA 
in the kidneys, adrenals, and vasculature to increase natriuresis, diuresis, and vasorelaxation 
(Espiner 1994). Levels of ANP and BNP are elevated in both human patients and animal 
models of heart failure and cardiac hypertrophy (Clerico et al. 1999; Knowlton et al. 1995). 
In addition to its key role in blood pressure regulation, the NPRA system also influences 
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cardiac growth in a blood-pressure-independent manner in mice (Lopez et al. 1995; Oliver et 
al. 1997; Knowles et al. 2001; Kishimoto et al. 2001). Importantly, we have demonstrated 
that quantitative changes in Npr1 gene expression have significant effects on both blood 
pressure and cardiac mass in mouse models (Knowles et al. 2001; Oliver et al. 1998). 
Finally, a functional deletion mutation that lies in the 5’ flanking region of the human NPR1 
gene and that causes a 70% decrease in transcription of the corresponding allele has been 
shown to be associated with hypertension and cardiac hypertrophy in Japanese individuals 
(Nakayama et al. 2000).
Although cDNA coding for the human NPR1 gene was first isolated in 1989 (Lowe et al. 
1989) and the structural organization of the gene is known (Takahashi et al. 1998), the full 
genomic sequence has not been determined. Here, we describe the genomic sequence of the 
human NPR1 gene and identify 10 common polymorphic sites in its noncoding regions. 
Functional analysis indicates that common haplotypes carrying these polymorphisms could 




A human genomic DNA library was made by using DNA that was partially digested with 
Mbo1, size selected, and ligated into BamH1 sites of the phage vector LambdaGEM-11 
(Promega). Two phage clones containing the NPR1 gene were isolated with polymerase 
chain reaction (PCR)-generated fragments of exon 1 (primers 4a and 4b, Table 1) and of 
exon 22 (primers 20a and 20e, Table 1) as probes. The entire coding and non-coding region 
of the gene was sequenced at the UNC Sequencing Core Facility at least once in both 
directions by using overlapping subclones and primers. The complete sequence has been 
submitted to Genbank (accession no. AF190631). The nucleotide positions in the text and 
figures refer to this sequence, counting the first nucleotide of ATG codon +1 and the first 
nucleotide upstream of the ATG codon as –1. Nucleotide sequence comparisons were made 
with GCG software (Genetics Computer Group).
Identification of common polymorphisms
Human DNA samples were isolated from blood samples or from fibroblasts of unrelated 
individuals (Maeda et al. 1983, 1986). In some cases, the racial origin of the sample was 
known. The study was approved by the institutional review boad of the University of the 
North Carolina. A PCR-based approach was used to amplify DNA fragments covering most 
of the NPR1 gene in six unrelated individuals (3 Caucasians and 3 African-Americans). 
Briefly, sets of overlapping primers (Table 1) were designed from appropriate exonic or 
intronic sequences and amplified by PCR with high-fidelity Pfu DNA polymerase 
(Stratagene). PCR products of approximately 1 kb were electrophoresed on agarose gels to 
verify their correct size, purified by using a QIAquick PCR purification kit (Qiagen), and 
sequenced by using the PCR primers.
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Polymorphic sites so identified were further characterized in samples from an additional six 
Caucasians, seven blacks, and 15 people of unknown racial origin by single-stranded 
confirmational polymorphism analysis (SSCP). PCR products were made covering the 
polymorphic regions of the NPR1 gene in a buffer containing 20 pmole each primer, 10% 
dimethylsulfoxide, 10 ng template DNA, Taq DNA polymerase (Boehringer Mannheim), 10 
mM dNTPs, and 0.1 mCi 32P-dCTP. After an initial denaturation step at 94°C for 2 min, 
reactions were cycled at 94°C for 1 min, 60–65°C for 1 min, and 72°C for 1 min, for 33 
cycles. The labeled PCR product (1 μl) was diluted into 9 μl 0.1% SDS, 20 mM EDTA, 95% 
formamide, 0.05% bromophenol blue, and 0.05% xylene cyanol. Samples were denatured 
for 10 min at 95°C, placed on ice, and separated in a 1× MDE gel matrix (FMC 
Bioproducts). After electrophoresis at 12 W for 3–4 h at room temperature, gels were dried 
and exposed overnight to Kodak films.
Reporter plasmid construction
To test the promoter function of the 5’ haplotypes, oligonucleotides were designed to PCR-
amplify a BamH1/Nco1 fragment containing the promoter region that extends upstream 770 
bp from the AUG start codon of the NPR1 gene. The PCR fragments amplified from 
genomic DNA from individuals carrying the three 5’ haplotypes were cloned into the Bgl2 
and Nco1 sites of the pGL3-basic luciferase reporter vector (Promega). To test the effects of 
3’ untranslated region (UTR) sequences on gene expression, we made a plasmid (PGK-PL2) 
by inserting an Xba1/Hind3 fragment containing the promoter for the mouse 
phosphoglycerorate kinase gene (PGK; Adra et al. 1987) into the pGL2-basic vector 
(Promega). The SV40 late poly(A) signal sequence of the PGK-GL2 plasmid was replaced 
by a 700-bp fragment containing the 3’UTR of the NPR1 gene that had been amplified by 
PCR from each of the three 3’ haplotypes. The correctness of all constructs was verified by 
sequencing, and sets of test plasmids were prepared simultaneously for each transfection 
experiment by using QIAGEN plasmid purification kits (QIAGEN). A CMVβGal plasmid 
containing the Escherichia coli galactosidase gene driven by a cytomegalovirus promoter 
(MacGregor and Caskey 1989) was a gift from Dr. MacGregor, at Emory University.
Reporter gene expression assay
Mouse aortic smooth muscle cells isolated from aorta of adult C57BL6 mice (Yasuda et al. 
2000) and 293 cells were cultured in DMEM containing 10% fetal calf serum. Cells cultured 
in 3-cm wells until 70% confluent were transfected with 2 μg luciferase reporter DNA 
mixed with 1 μg CMVβGal DNA by using lipofectamine (Life Technologies) according to 
the protocol of the supplier. Cells were harvested 48 h after transfection, lysed in 300 μl of 
lysis reagent (Promega), and frozen at –70oC until analyzed. The lysates were centrifuged at 
16,500 g for 10 min at 4°C, and 20 μl of the supernatant was mixed with 100 μl of 
Luciferase Assay Reagent (Promega). Samples were analyzed in a Monolight 2010 
luminometer (BD PharMingen). To normalize the transfection efficiency, β-Gal activity was 
determined for each extract by using the assay system from Promega according to their 
protocol. In each experiment, transfection was carried out in duplicate or triplicate for each 
reporter plasmid, and transcriptional ability was calculated relative to the expression of the 
most common haplotype as 100%. Experiments were repeated three to four times, and 
statistical analysis by ANOVA was performed by using the JMP software package (SAS 
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Institute). Data was expressed as mean ± SEM, and means for all pairs were compared using 
Tukey-Kramer HSD.
Results
Human NPR1 gene structure
The human NPR1 gene spans approximately 16 kb and contains 22 exons and 21 introns. 
The 5’ region of the gene, including both the 5’UTR and exon 1, is unique with a high G/C 
content of 70% (Fig. 1), which is much greater than the 41% G/C content average of the 
human genome (Lander et al. 2001). This region is also particularly rich in CpG 
dinucleotides, containing 158 within the roughly 1600 bp of the sequence (11%). For 
comparison, in the remaining 14.5 kb, there are only 246 CpG dinucleotides (1.7%). 
Another notable sequence motif is in intron 1 where an approximately 200-bp stretch of 
pyrimidines occurs in the sense strand. Such sequences are known to form Z-DNA and triple 
helices and may be involved in transcriptional regulation (Nordheim and Rich 1983). The 
intronic regions are interspersed with multiple repeat elements, including six Alu repeats 
(introns 4, 7, 8, 20), two mammalian-wide interspersed repeats (intron 20), and three 
elements from the medium reiteration repeats (intron 20).
Polymorphisms in the NPR1 gene
To search for common polymorphisms in the NPR1 gene, we performed direct sequence 
analysis of PCR products amplified along the NPR1 gene from three Caucasians and three 
African-Americans (Table 2) with primers listed in Table 1. The analyzed region from the 
12 chromosomes covers approximately 10 kb DNA excluding Alu repeats. Using these data, 
we identified ten polymorphic sites in the noncoding sequence of NPR1 (nos. 1–10; Fig. 1). 
SSCP analyses were then used to genotype a total of 10 African-Americans, 9 Caucasians 
and 15 individuals of unknown race (Table 2). Our early observations (Maeda et al. 1983) 
and more extensive studies (Wang et al. 1998) showed that base substitution polymorphisms 
were more frequent than length differences by a ratio of about 12:1 in the human genome. 
However, in the regions of the NPR1 gene that we surveyed, we found that five of the 10 
polymorphisms were length differences: a (CT)n dinucleotide repeats at nucleotide –293 in 
the promoter region (site 1, n=6, 10, or 11), a length difference of Cn at nucleotide 8927 in 
intron 14 (site 6, n=6 or 7), a highly variable number of dinucleotide repeats at nucleotide 
10,955 in intron 19 (site 7), a length difference of Cn at nucleotide 14,319 in the 3’UTR (site 
8, n=3 or 4), and a 4-bp insertion/deletion of AGAA at nucleotide 14,649 also in the 3’UTR 
(site 9). The dinucleotide repeats in intron 19 were complex and highly variable, with the 
NPR1 gene being isolated in a phage clone having (CT)19GT(CT)15(CA)13. The equivalent 
sequences from most of the PCR fragments were too complex, because of heterozygosity 
and because of PCR artifacts to determine the exact numbers of repeats, but they clearly 
differed in different individuals.
Of the five base substitutions, G/A at nucleotide –77 in the 5’UTR (site 2) and G/A at 
nucleotide 8812 in intron 14 (site 5) were present in several individuals (Table 2), whereas 
three (site 3 at nucleotide 1665, site 4 at nucleotide 1678 in intron 2, and site 10 at 
nucleotide 14,802 in the 3’UTR) were each seen in only one chromosome. Our finding of 
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relatively few SNP sites in the sequenced region is notable. In mammalian genome, the 
regions very rich in G/C and CpG dinucleotides, such as we have found in exon 1 of NPR1, 
are generally associated with an increased frequency of base substitution polymorphisms 
(Lander et al. 2001). Nevertheless, all six individuals whom we examined shared an 
identical sequence in exon 1 of 770 bp. The conservation of sequence included the 
synonymous positions in the exon suggesting that this has an importance additional to that 
of amino acid sequence conservation, perhaps in controlling gene expression.
Common haplotypes
Three polymorphisms, viz., (CT)6 at nucleotide –293, A at nucleotide –77, and A at 
nucleotide 8927, were in the same three individuals, all of them being African-American. 
(CT)10 and (CT)11 were found in both African-Americans and in Caucasians. Despite the 
finding that nucleotides 8812 and 8927 in intron 14 were about 9 kb away from nucleotides 
–293 and –77 in the 5’ region, these four polymorphic sites were in strong linkage 
disequiliblium, and individuals with C6 at nucleotide 8927 always had (CT)10 at nucleotide 
–293. Together, the polymorphisms at sites 1–6 in the 5’ region of the gene fell into three 
common haplotypes, which we designated as “CT6”, “CT10”, or “CT11”, with approximate 
overall frequencies of 6%, 44%, and 50%, respectively (Fig. 2).
The length polymorphism of 3C or 4C at nucleotide 14,319 in the 3’UTR was found in both 
African-Americans and Caucasians, whereas two of the three NPR1 genes missing AGAA at 
nucleotide 14,649 were found in Caucasians, and one was in an individual of unknown 
racial origin. The individuals with AGAA deletion had at least one 4C at nucleotide 14,319. 
Thus, polymorphisms at these two sites in the 3’ region of the gene constituted three 
common haplotypes, “3-plus”, “4-plus”, and “4-minus”, with frequencies of 39%, 57%, and 
4%, respectively (Fig. 2). The three common haplotypes in the 5’ region of the gene 
appeared to be randomly associated with the three common haplotypes in the 3’ region of 
the gene. For example, “CT11” in the 5’ was seen with all three 3’ haplotypes. Similarly, “4-
minus” in the 3’ region was seen with either “CT11” or “CT10” in the 5’ region. The 
observed frequencies in Table 2 do not differ significantly from those expected from random 
association between the 5’ haplotypes and 3’ haplotypes (Ξ2=7.47, P=0.5), suggesting that 
frequent crossovers have occurred between them. A long stretch of highly variable 
dinucleotide repeats in intron 19 is the likely cause of frequent crossovers between the 5’ 
and 3’ parts of the NPR1 gene.
Functional polymorphisms
To test whether the common genetic variants of the human NPR1 gene affected levels of 
gene expression, we examined the transcriptional activity of the three variants of the 
proximal promoter that contains the polymorphic sites 1 and 2. Mouse aortic smooth muscle 
(SM) cells were transfected with DNA constructs containing the three variants driving the 
luciferase reporter gene. SM cells expressed the Npr1 gene, as readily demonstrated by 
Northern blots (not shown), even though the expression of all the reporter constructs was 
only 5%–10% of the expression from the PGK-GL2 control plasmid. Nevertheless, we 
found that the transcriptional activity of the CT6 promoter was significantly higher 
(145±12%) compared with the activities of CT10 (104±8%) and CT11 (100±3%) promoters 
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(Fig. 3A). It should be noted that the CT6 promoter also differed from others in that it had A 
at site 2 in the 5’UTR instead of G.
The expression levels of constructs containing the three 3’UTR variants were also assessed 
by transient transfection into 293 cells. The absolute luciferase activities obtained after 
transfection of the 293 cells were much higher than in SM cells, but the relative expression 
levels of different constructs were the same. The data from four experiments with SM cells 
and four experiments with 293 cells were therefore analyzed together with ANOVA, taking 
cell type and haplotype as two variants. Compared to the most common 4-plus haplotype 
(100±5%), the reporter constructs with 3’UTR of 3-plus and 4-minus haplotypes had 
significantly lower expressions of 70±6% and 78±4%, respectively (Fig. 3B). The combined 
effects of the promoter polymorphisms and 3’UTR polymorphisms can therefore affect the 
expression of the NPR1 genes by as much as a factor of two.
Discussion
Using DNA from a relatively small number of unrelated individuals, we have identified ten 
polymorphic sites forming three haplotypes in the 5’ and three haplotypes in the 3’ 
noncoding regions of the human NPR1 gene, a candidate gene for affecting the incidence 
and severity of essential hypertension and cardiac hypertrophy. Transient expression 
analysis in cultured cells has revealed that one of the 5’ haplotypes, “CT6”, has 45% higher 
promoter activity than the other two (“CT10” and “CT11”), whereas the 3’UTR of two of 
the 3’ haplotypes, “3-plus” and “4-minus”, reduces the reporter gene function by 30% 
compared with the “4-plus” haplotype. One of the common 5’ haplotypes, with a frequency 
of approximately 6%, has potentially protective effects because it increases NPRA levels, 
while two of the common 3’ haplotypes, with a combined frequency of 43%, have 
potentially damaging effects.
The differences in promoter sequences that we have demonstrated could clearly influence 
the transcriptional activity of the gene. However, it is not clear how the 12-bp versus 20-bp 
or 22-bp stretch of CT dinucleotides at nucleotide –293 and/or the G to A change at 
nucleotide –77 leads to a 45% increase in promoter function. Nucleotide sequence 
comparisons of human (AF190631), rat (J05677), and mouse (AJ307712) indicate that the 
region containing the CT dinucleotide repeats is downstream of a long homology block (–
466 to –347) that contains a putative SP1 site, although the distance between this homology 
region and the ATG start codon is not conserved between humans and rodents. 
Polymorphisms in the 5’ regions of genes are being increasingly recognized as important in 
the pathogenesis of complex diseases, including hypertension. For example, the M235T 
polymorphism that is associated with essential hypertension (Jeunemaitre et al. 1992) in the 
human angiotensiogen gene is in virtually complete linkage disequilibrium with a functional 
polymorphism in the promoter sequence (Inoue et al. 1997). Similarly, changes in the 
number of tandem repeats in the 5’UTR of the P450 prostacyclin synthase gene CYP8A1 
cause differences in its transcriptional activity, thereby moderating inflammatory processes 
(Chevalier et al. 2001). Moreover, rare variant chromosomes with single base changes in the 
promoter of the hepatocyte nuclear factor-1α that decrease transcriptional activities have 
been found in families with monogenic diabetes (Godart et al. 2000).
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Less attention has been devoted to assessing the effects on gene expression of 
polymorphisms in 3’UTR regions, but the importance of these sequences on mRNA stability 
and translation has long been recognized (Ross 1995). We were surprised to find that having 
3C or 4C at 30 bp downstream of the stop codon in the NPR1 transcript significantly 
affected expression. The nucleotide sequence of the first 100 bp in the 3’UTR is well 
conserved, although not identical, between humans and rodents. Possibly, this sequence 
influences the secondary structure of the transcript and so affects its stability or translation. 
In this regard, we note that a potential 27-bp stem and 6-bp loop structure with the stop 
codon in the loop can form in the RNA involving the sequence immediately 5’ to the 3C/4C 
polymorphic site. The sequence with 4C, but not that with 3C, could interfere with this 
stem-loop formation by forming another, although less stable, stem-loop structure involving 
some of the same nucleotides. Stem-loop structures in the 3’UTR have been shown to be 
important determinants of message stability in some genes (Putland et al. 2002). C-rich 
sequences are in some cases important for post-transcriptional regulation as exemplified by 
the α2-globin and collagen α1 genes (Weiss and Liebhaber 1995; Stefanovic et al. 1997). 
Other examples of functional 3’UTR polymorphisms include a significant association 
between a common 5-bp insertion-deletion polymorphisms in an AU rich element within the 
3’UTR of the protein phosphatase 1 PPP1R3 gene and plasma glucose in Canadian Oji-Cree 
(Hegele et al. 1998).
Essential hypertension and cardiac hypertrophy are frequent and important causes of 
morbidity. Thus, the identification, in the general human population, of common haplotypes 
that lie within the NPR1 gene and that potentially affect gene expression by as much as two-
fold has important implications. Previously, we have shown that quantitative changes in 
Npr1 expression affect blood pressure and cardiac hypertrophy (Oliver et al. 1998). In that 
study, the alteration of gene expression levels, achieved by varying the number of copies of 
the Npr1 gene, demonstrated that blood pressure was inversely correlated with the amount 
of Npr1 expression and that a two-fold difference in mRNA levels resulted in about a 10 
mmHg difference in blood pressures of the animals. Our more recent observations indicate 
that Npr1 expression inversely also affects cardiac mass in a dose-dependent manner 
(Knowles et al. 2001). The concept that NPR1 quantitatively influences hypertension and 
cardiac hypertrophy in humans is further enhanced by a recent report that heterozygosity for 
an 8-bp deletion in the promoter region is associated with essential hypertension and cardiac 
hypertrophy in the Japanese population (Nakayama et al. 2000). Although this particular 8-
bp deletion is not present in the small set of samples that we have studied, our analyses show 
the presence of far more common alleles in African-Americans and in Caucasians that affect 
expression levels, albeit to a lesser degree. Assuming that the 5’ and 3’ haplotypes that we 
have uncovered are randomly associated, we estimate that NPR1 gene expression levels in 
the general population can differ up to two-fold (1.45 versus 0.70) as a consequence of these 
differences, with the upper and lower quantiles differing by about 20% (1.02 versus 0.85 
with mean expression levels 0.92). If the physiological consequence of changes in NPR1 
gene expression levels in mice and humans are similar, the common NPR1 alleles could 
therefore be responsible for as much as 10 mmHg in blood pressure, and for a significant 
part of the susceptibility to cardiac hypertrophy in the population. Further studies with a 
larger number of individuals are clearly needed to determine more precisely the frequencies 
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of the polymorphisms that we have described and the frequencies at which the 5’ and 3’ 
haptotypes recombine. An extensive population-based study will probably be required to 
determine whether these NPR1 alleles do indeed account for any differences in the risk of 
hypertension or cardiac hypertrophy.
Genetic variations affecting complex diseases and traits are probably common in the general 
population and are likely to involve many genes. Small effects of individual variants, such 
as those that we have found in NPR1, may easily be masked by the heterogeneity of human 
populations, by gene-gene interactions, and by the effects of environmental differences. 
Consequently, the recognition of such small effects in genome-wide association studies will 
be difficult and will require a large number of subjects combined with sophisticated 
statistical approaches able to analyze multiple loci simultaneously (Xiong et al. 2002). The 
ability to go back and forth between association studies in humans and gene alteration in 
mice should therefore continue to play an integral part in increasing our understanding of 
genetic factors that influence the complex traits of mankind.
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Structure and polymorphisms of the human NPR1 gene. The gene covers approximately 16 
kb. Numbered long vertical bars Exons, horizontal arrowheads Alu repeats in introns, 
hatched line a G/C-rich region covering the promoter, exon 1 and 5’ part of the intron 1, 
open box C/T-rich stretch in intron 1, upward arrows with numbers polymorphic sites. The 
polymorphisms and their frequencies of observation are listed below. The nucleotide 
positions in parentheses are based on the sequence in AF190631 (Genbank) counting the 
first nucleotide of the ATG codon as 1. Frequency indicates the number of chromosome 
observed/genotyped
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Common haplotypes of the NPR1 gene. There are three common haplotypes, designated 
“CT6”, “CT10”, and “CT11”, encompassing polymorphisms 1, 2, 5, and 6 in the 5’ region 
of the gene (Fig. 1). There are three common haplotypes, “3-plus”, “4-plus”, and “4-minus”, 
in the 3’ region of the gene encompassing polymorphisms 8–10 in Fig. 1. The 5’ and 3’ 
haplotypes are not linked; they flank a region in intron 19 that contains a highly variable 
number of dinucleotide repeats. Approximate distances between the polymorphic sites are 
shown. The frequencies of the 5’ haplotypes are from site 1
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A, B Luciferase activity of reporter constructs. A Promoter activities were determined in 
transfected mouse aortic smooth muscle cells. Activity is expressed in percentages relative 
to the ratios of luciferase/β-galactosidase activities with the “CT11” promoter as 100%. Bars 
Means ± SE from four experiments (n=12 individual wells). P<0.001 by ANOVA. B 3’UTR 
function was examined by transfection of constructs in 293 cells (four experiments) and in 
mouse aortic smooth muscle cells (four experiments). Activities are expressed as 
percentages relative to that of “4-plus” variant as 100%. Bars Means ± SE from the eight 
experiments combined (n=18 individual wells). P<0.0001 by ANOVA. Asterisks in A, B 
indicate the constructs whose expression differs significantly from others
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